| Primary |
| Multiple Allergies |
50.0% |
| Product Used For Unknown Indication |
25.0% |
| Prolactinoma |
25.0% |
|
| Convulsion |
40.0% |
| Arrhythmia |
20.0% |
| Death |
20.0% |
| Paranoia |
20.0% |
|
| Secondary |
| Product Used For Unknown Indication |
48.0% |
| Completed Suicide |
28.0% |
| Nasal Dryness |
8.0% |
| Asthma |
4.0% |
| Convulsion |
4.0% |
| Depression |
4.0% |
| Urticaria Chronic |
4.0% |
|
| Drug Ineffective |
22.2% |
| Toxicity To Various Agents |
22.2% |
| Incorrect Route Of Drug Administration |
11.1% |
| Lethargy |
11.1% |
| Torsade De Pointes |
11.1% |
| Unevaluable Event |
11.1% |
| Visual Acuity Reduced |
11.1% |
|
| Concomitant |
| Product Used For Unknown Indication |
29.4% |
| Gastrooesophageal Reflux Disease |
7.1% |
| Asthma |
6.8% |
| Hypersensitivity |
6.0% |
| Hypertension |
5.5% |
| Pain |
5.0% |
| Chronic Obstructive Pulmonary Disease |
4.7% |
| Diabetes Mellitus |
4.5% |
| Cardiac Disorder |
4.2% |
| Plasma Cell Myeloma |
3.4% |
| Multiple Sclerosis |
3.1% |
| Blood Cholesterol Increased |
2.9% |
| Blood Cholesterol Abnormal |
2.6% |
| Colitis |
2.6% |
| Bipolar Disorder |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Hepatitis C |
2.1% |
| Vitamin Supplementation |
2.1% |
| Anxiety |
1.6% |
| Atrial Fibrillation |
1.6% |
|
| Vomiting |
15.0% |
| Nausea |
6.7% |
| Priapism |
6.7% |
| White Blood Cell Count Increased |
6.7% |
| Pericarditis |
5.0% |
| Product Substitution Issue |
5.0% |
| Somnolence |
5.0% |
| Thrombocytopenia |
5.0% |
| Tremor |
5.0% |
| Urinary Tract Infection |
5.0% |
| Weight Increased |
5.0% |
| Convulsion |
3.3% |
| Head Injury |
3.3% |
| Lower Respiratory Tract Infection |
3.3% |
| Platelet Count Decreased |
3.3% |
| Pruritus |
3.3% |
| Rectal Haemorrhage |
3.3% |
| Sinusitis |
3.3% |
| Throat Irritation |
3.3% |
| Urticaria |
3.3% |
|
